Time-restricted Eating Among Pregnant Females With Severe Obesity
- Conditions
- Time Restricted EatingObesity, MorbidPregnancy Weight Gain
- Interventions
- Behavioral: Time Restricted Eating
- Registration Number
- NCT06477120
- Lead Sponsor
- University of Illinois at Chicago
- Brief Summary
In the United States, severe obesity (body mass index (BMI) ≥ 40.0 kg/m2) affects approximately 10% of females of reproductive age with Black females disproportionately burdened (16%). Severe obesity is a significant predictor of adverse perinatal outcomes including gestational diabetes mellitus, pre-eclampsia, premature birth, and at its most severe, fetal death, birth defects and a three-fold greater risk of maternal mortality - outcomes that also disproportionately affect Black females. Observational studies suggest weight maintenance and even modest body fat loss and altering the maternal metabolic milieu (availability of glucose and lipids) in the gestational period may be important to reducing perinatal health risks among pregnant females with severe obesity. The proposed research aims to assess time-restricted eating in the 2nd and 3rd trimesters of pregnancy to explore the effects on maternal weight, and perinatal health outcomes compared to standard clinical care.
- Detailed Description
Severe obesity is a contributor to adverse perinatal outcomes and Black females are disproportionately burdened. The prevalence of severe obesity is on the rise in the United States (U.S.), having increased from 6.4% of the adult population in 2011-2012 to just over 9% of adults in 2017-2018. The prevalence of severe obesity among reproductive age females is approximately 10%. This is an alarming statistic given severe obesity is a predictor of adverse perinatal outcomes including gestational diabetes mellitus, preeclampsia, premature birth (both spontaneous and medically indicated), and at its most severe, fetal death, birth defects, and a three-fold greater risk of maternal mortality. Observational studies suggest weight maintenance and even modest body fat loss and altering the maternal metabolic milieu (availability of glucose and lipids) in the gestational period may be important to reducing perinatal health risks among pregnant females with severe obesity. Existing lifestyle interventions (calorie control/dietary pattern changes/physical activity) have showed modest effects on attenuating excess gestational weight gain and modest effects on perinatal health outcomes among pregnant females with obesity. Time- restricted eating, where an individual simply watches the clock and consumes calories within a particular eating window, is a simple and highly accessible eating pattern that has the potential to minimize gestational weight gain, reduce excess glucose and lipids, and improve metabolic health among pregnant females with severe obesity all of which could translate to improved perinatal health outcomes. Yet there are no clinical trials of time-restricted eating in pregnancy. The investigators aim to test the safety, feasibility, and acceptability of time-restricted eating among 80 pregnant females with severe obesity. The investigators will examine time-restricted eating safety, feasibility and acceptability (8-hr eating window in the 2nd trimester \& 10-hr eating window in the 3rd trimester), and explore its effects on weight, cardiometabolic risk markers and perinatal health outcomes vs. Standard Care. The intervention will begin at \~17 weeks gestational age and continue through admission for labor and delivery. The study will involve weekly meetings with a nutritionist, and research visits at baseline (\~17 weeks gestational age), 27-29 weeks gestational age and 35-37 weeks gestational age as well as monthly check-ins for maternal and fetal health monitoring. Maternal and neonatal data from labor and delivery will also be collected from electronic health records. Glucose will be continuously monitored for 10 days at 20 weeks gestational age and 34 weeks gestational age (optional). The goal of our work is to reduce and prevent adverse perinatal outcomes among pregnant females with severe obesity. Given the relative simplicity of time-restricted eating it can be easily disseminated in clinic demonstrating its strong potential for wide-scale public health impact.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 80
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Time-restricted eating Time Restricted Eating Participants randomized to the time-restricted eating arm will be instructed to eat ad libitum during an 8-hr window daily 11am - 7pm in the 2nd trimester and 10-hr eating window from 10am - 8pm in the 3rd trimester and abstain from caloric foods and beverages for the remaining 14-16 hours. During the eating window there will be no restrictions on types or quantities of foods consumed. Moreover, participants will not be required to monitor calorie intake during the ad libitum eating period. During the fasting period, participants will be encouraged to drink plenty of water and will be allowed to consume calorie-free beverages.
- Primary Outcome Measures
Name Time Method Maternal Complete Blood Count Baseline (14-17 weeks gestational age) and monthly through labor and delivery A laboratory test that measures the quantity and quality of blood cells and other components: Red blood cells (RBCs), White blood cells (WBCs), Platelets (thrombocytes), Hemoglobin, and Hematocrit from a Blood Sample
Intervention Acceptability 25-27 weeks gestational age and 35-37 weeks gestational age Semi-structured interviews
Recruitment Feasibility From 6 months through 32 months (the funding period is 36 months) ≥ 30% of those approached enroll
Non-stress Test for Fetal Safety 25-27 weeks gestational age and 35-37 weeks gestational age Measured with a fetal monitor to examine baby's heart rate over time (usually 20 to 30 minutes, but sometimes up to an hour
Maternal Glycemic Health 24-28 weeks gestational age Oral Glucose Tolerance Test
Fetal Heart Tones Monthly 16-32 weeks gestational age and twice monthly 33 weeks gestational age up through delivery Measured during clinical care visits
- Secondary Outcome Measures
Name Time Method Fasting Blood Lipids Baseline (14-17 weeks), 25-27 weeks gestational age, 35-37 weeks gestational age Cholesterol and triglycerides
Fasting insulin Baseline (14-17 weeks), 25-27 weeks gestational age, 35-37 weeks gestational age Measured in serum
Systolic Blood Pressure Baseline (14-17 weeks), 25-27 weeks gestational age, 35-37 weeks gestational age Measured with participant in a seated position using an automated cuff
Diastolic Blood Pressure Baseline (14-17 weeks), 25-27 weeks gestational age, 35-37 weeks gestational age Measured with participant in a seated position using an automated cuff
Body weight Baseline (14-17 weeks), 25-27 weeks gestational age, 35-37 weeks gestational age Body weight in kilograms
Fasting blood glucose Baseline (14-17 weeks), 25-27 weeks gestational age, 35-37 weeks gestational age Measured in serum
C-reactive protein Baseline (14-17 weeks), 25-27 weeks gestational age, 35-37 weeks gestational age Measured in plasma
Trial Locations
- Locations (1)
University of Illinois at Chicago College of Applied Health Sciences
🇺🇸Chicago, Illinois, United States